These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21207734)

  • 1. [Acute exacerbations of idiopathic pulmonary fibrosis].
    Lazor R; Bonetti A; Nicod LP
    Rev Med Suisse; 2010 Nov; 6(272):2228-30, 2232. PubMed ID: 21207734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
    Richeldi L
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
    Ryerson CJ; Cottin V; Brown KK; Collard HR
    Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
    Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
    Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
    Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute exacerbations of interstitial lung disease.
    Azadeh N; Moua T; Baqir M; Ryu JH
    Expert Rev Respir Med; 2018 Apr; 12(4):309-313. PubMed ID: 29486130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses.
    Morawiec E; Tillie-Leblond I; Pansini V; Salleron J; Remy-Jardin M; Wallaert B
    Eur Respir J; 2011 Dec; 38(6):1487-9. PubMed ID: 22130770
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute exacerbation of idiopathic pulmonary fibrosis.
    Hyzy R; Huang S; Myers J; Flaherty K; Martinez F
    Chest; 2007 Nov; 132(5):1652-8. PubMed ID: 17998366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exacerbations complicating interstitial lung disease.
    Ryerson CJ; Collard HR
    Curr Opin Pulm Med; 2014 Sep; 20(5):436-41. PubMed ID: 25032813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30884853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.
    Luppi F; Cerri S; Taddei S; Ferrara G; Cottin V
    Intern Emerg Med; 2015 Jun; 10(4):401-11. PubMed ID: 25672832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbations of idiopathic pulmonary fibrosis.
    Antoniou KM; Wells AU
    Respiration; 2013; 86(4):265-74. PubMed ID: 24157720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
    Cuerpo S; Moisés J; Hernández-González F; Benegas M; Ramirez J; Sánchez M; Agustí À; Sellares J
    Chron Respir Dis; 2019; 16():1479973119869334. PubMed ID: 31431063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of idiopathic pulmonary fibrosis.
    Kim HJ; Perlman D; Tomic R
    Respir Med; 2015 Jun; 109(6):661-70. PubMed ID: 25727856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.
    Biondini D; Balestro E; Sverzellati N; Cocconcelli E; Bernardinello N; Ryerson CJ; Spagnolo P
    Expert Rev Respir Med; 2020 Apr; 14(4):405-414. PubMed ID: 31994940
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report.
    Hirai K; Homma T; Yamaguchi F; Yamaguchi M; Suzuki S; Tanaka A; Ohnishi T; Sagara H
    BMC Pulm Med; 2019 Jan; 19(1):15. PubMed ID: 30642317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.
    Kawamura K; Ichikado K; Ichiyasu H; Anan K; Yasuda Y; Suga M; Sakagami T
    BMC Pulm Med; 2019 Jun; 19(1):113. PubMed ID: 31238929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.